Zum Inhalt springen
- {{#headlines}}
- {{title}} {{/headlines}}
Profil
| Derzeitige Stellung | Professor W-3 und Äquivalente |
|---|---|
| Fachgebiet | Pharmakologie,Biochemie |
| Keywords | Biochemistry, Human Genetics, Pharmacogenetics, Clinical Pharmacology, Drug Metabolism & Pharmacokinetics |
Aktuelle Kontaktadresse
| Land | Simbabwe |
|---|---|
| Ort | Harare |
| Universität/Institution | African Institute of Biomedical Science and Technology (AiBST) |
Gastgeber*innen während der Förderung
| Prof. Dr. Julia Stingl | Abteilung Klinische Pharmakologie und Pharmakoepidemiologie, Ruprecht-Karls-Universität Heidelberg, Heidelberg |
|---|---|
| Prof. Dr. Julia Stingl | Ruprecht-Karls-Universität Heidelberg, Heidelberg |
| Beginn der ersten Förderung | 01.04.2025 |
Programm(e)
| 2024 | Forschungspreis-Programm auf Gegenseitigkeit für Wissenschaftler*innen aus dem Ausland |
|---|
Projektbeschreibung der*des Nominierenden
| Professor Masimirembwa is a leading scientist in the field of pharmacogenetics and has made pioneering work deciphering the genomic diversity of African populations and its implications for the safe and efficacious use of medicines. He combines human genetics, drug metabolism and pharmacokinetics research in predicting drug response. One important result of his work is a genetic test and dosing algorithm that is being clinically validated across Africa. During his research stays in German he will explore the implementation of pharmacogenetic diagnostics in patients taking multiple drugs, and will adopt it to the needs in African patients. He will also develop training material for the uptake of pharmacogenetics by medical practitioners. |